BNET Industries

  • Private
  • US
Dow Jones Description

Invitrogen is committed to being the leading provider of novel fluorescent reagents and detection solutions that advance scientific and biomedical research worldwide. Supplying superior Molecular Probes products and services, together with striving for customer and employee satisfaction, will be the driving forces of our organization.

Senior Vice President
Ben Bulkley
Contact Information

PO Box 22010

Eugene, Oregon 97402-0469

www.biopixels.c...

1 800 438 2209

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

News & Analysis

electronics and invitrogen corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Ben Bulkley Senior Vice President
David U'Prichard Director

Board of Directors

Name (plus bio) Position
Donald W Grimm Board Member
Raymond V. Dittamore Board of Directors
W. Ann Reynolds PhD Board of Directors

Organization Position Status
Invitrogen Corporation Senior Vice President Current
UCSD-CONNECT Director Current

Organization Position Status
Care Capital, LLC Venture Partner Current
Red Abbey, LLC Senior Advisor and Venture Partner Current
University of Glasgow Honorary Professor Current
Red Abbey, LLC Advisor Current
Northwestern University Associate Professor Current
Glasgow University Honorary Professor Current
Genematrix, Inc. Board Director Current
Exsar Corporation Board Director Current
Guilford Pharmaceuticals, Inc. Director Current
Invitrogen Corporation Director Current
Cyclacel Limited Board of Directors Current
GlaxoSmithKline Plc President Former
SmithKline Beecham Corporation President of Research and Development Former
Druid Consulting President Former
Apax Partners Ltd. Venture Partner Former
Northwestern University School of Medicine Associate Professor of Pharmacology and Neurobiology Former
Biotechnology Industry Organization member Former
GlaxoSmithKline Plc Chairman of Research and Development Former
SmithKline Beecham Corporation Chairman of R&D Former
Biotechnology Industry Organization Board Member Former
University of Kansas Ph.D. in Pharmacology Former
University of Kansas MS Former
University of Glasgow B.Sc. in Pharmacology Former

Organization Position Status
Oligoperfect Founder, Chairman and President, Strategic Design Current
Pittsburgh Tissue Engineering Initiative, Inc Founder, Chairman and President, Strategic Design Current
Resgen Inc. Founder, Chairman and President, Strategic Design Current
Emiliem, Inc. Founder, Chairman and President, Strategic Design Current
Hamilton BioVentures President Current
Molecular Probes Founder, Chairman and President, Strategic Design Current
Biolayer Corporation Limited Founder, Chairman and President, Strategic Design Current
Strategic Design President Current
IDEXX Laboratories, Inc. Founder, Chairman and President, Strategic Design Current
Seqanswers Founder, Chairman and President, Strategic Design Current
Microseq Founder, Chairman and President, Strategic Design Current
Industry Ventures Founder, Chairman and President, Strategic Design Current
Olink Founder, Chairman and President, Strategic Design Current
Ionsource, LLC Founder, Chairman and President, Strategic Design Current
Bioreliance Corporation Founder, Chairman and President Current
Aegis Therapeutics, LLC Executive Chairman Current
Strategic Design Chairman Current
San Diego Regional Chamber of Commerce Vice Chair Current
Cellzdirect, Inc. Board of Directors Current
High Throughput Genomics, Inc. Board of Directors Current
Hamilton BioVentures Director Current
Intec Telecommunications Board Member Current
Invitrogen Corporation Board Member Current
University of Pittsburgh School of Pharmacy Board Member Current
Angstrom Pharmaceuticals, Inc. Board of Directors Current
Multiple Peptide Systems Inc Board of Directors Current
Scripps Clinic Board Member Current
Hybritech, Inc. CEO Former
Dura Pharmaceuticals, Inc. Chief Executive Officer Former
Biosource International, Inc. Founder, Chairman and President, Strategic Design Former
Hybritech, Inc. President Former
Copenhagen Capacity Managing Director Former
Hybritech, Inc. Director of West Coast Pharmaceutical Sales Former
Eli Lilly and Company Director of Pharmaceutical Market Research Former
Eli Lilly and Company management positions Former
U.S. Army Officer Former
Xcel Pharmaceuticals, Inc. Former
Verus Pharmaceuticals Former
Cadence Pharmaceuticals, Inc. Former
Hybritech, Inc. Chairman Former
Hybritech Chairman Former
Biovail Corporation Chairman Former
Pharmaceutical Market Research Director Former
Roundtable Inc. Board of Directors Former
Bioreliance Corporation Director Former
Somaxon Pharmaceuticals, Inc. Board of Directors Former
California Healthcare Institute, Inc. Board of Directors Former
University of Pittsburgh M.B.A. Former
Pittsburgh Tissue Engineering Initiative, Inc M.B.A. Former
Baldwin-Wallace College Master's Degree In Business Administration Former
Pittsburgh Tissue Engineering Initiative, Inc B.S. In Pharmacy Former
University of Pittsburgh B.S. In Pharmacy Former

Raymond V. Dittamore has served as a Director of the Company since December 2002. Mr. Dittamore is a retired audit partner of Ernst & Young LLP, an international accounting firm. Mr. Dittamore retired in 2001 after 35 years of service with that firm, including 14 years as the managing partner of the firms San Diego office. Mr. Dittamore is also a director of Invitrogen Corporation, Gen-Probe Incorporated, and Digirad Corporation. Mr. Dittamore received a B.S. degree from San Diego State University.

Organization Position Status
QUALCOMM Incorporated Board of Directors Current
Molecular Probes Director Current
Invitrogen Corporation Board of Directors Current
IDEXX Laboratories, Inc. Board of Directors Current
Biolayer Corporation Limited Director Current
Ionsource, LLC Board of Directors Current
Microseq Board of Directors Current
Pittsburgh Tissue Engineering Initiative, Inc Board of Directors Current
Industry Ventures Board of Directors Current
Gen-Probe Inc. Board of Directors Current
Applied Molecular Evolution, Inc. Director Current
Ernst & Young partner Former
Ernst & Young collaborative editor Former
Digirad Corporation Board of Directors Former
San Diego State University B.S. Former
QUALCOMM Incorporated member Former

W. Ann Reynolds, 71, formerly President and Professor of Biology at The University of Alabama at Birmingham, located in Birmingham, Alabama, until 2002. Director since 2006; formerly a Director of OCD since 1993. A graduate of Kansas State Teachers College and the University of Iowa, where she earned a Ph.D. degree, Dr. Reynolds previously served as Chancellor of the City University of New York and as Chancellor of the California State University System. In prior years, she was Provost of the Ohio State University and Professor of Anatomy and Vice Chancellor for Research at the University of Illinois at the Medical Center. Dr. Reynolds is a director of Humana, Inc., Abbott Laboratories, Invitrogen Corporation, and the News-Gazette, Champaign, Illinois.

Organization Position Status
News Gazette Inc. Director Current
Humana Inc. Board of Directors Current
Abbott Laboratories Board of Directors Current
Owens Corning Board of Directors Current
Industry Ventures Board of Directors Current
Business-Higher Education Forum Member of The Board of The Champaign, Urbana News Gazette Current
Olink Board of Directors Current
KMG America Corporation Member of The Board of The Champaign, Urbana News Gazette Current
IDEXX Laboratories, Inc. Board of Directors Current
Resgen Inc. Board of Directors Current
Maytag Corporation Board of Directors Current
Ionsource, LLC Board of Directors Current
Pittsburgh Tissue Engineering Initiative, Inc Board of Directors Current
Microseq Board of Directors Current
Abms Member Board of Directors Current
Invitrogen Corporation Board of Directors Current
The University of Alabama at Birmingham President Former
University of Illinois Professor Former
University of Illinois College of Medicine Research Professor Former
Emporia State University M.S. Former
Emporia State University Bachelors Degree In Biology Former
advertisement
advertisement